Skyhawk ’s latest biopharma collaboration is worth up to $1.8B

Skyhawk has also previously unveiled partnerships with the likes of Vertex Pharmaceuticals Inc., Bristol Myers Squibb, Takeda Pharmaceuticals, Genentech and Biogen Inc.

Source: bizjournals.com Health Care:Biotechnology headlines - April 23, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news